Biliary excretion of antipyrine and its metabolites after cholecystectomy.
作者信息
Mönig H, Wilhelmy J, John S, Ohnhaus E E
出版信息
Br J Clin Pharmacol. 1988 Feb;25(2):279-80. doi: 10.1111/j.1365-2125.1988.tb03304.x.
Abstract
摘要
相似文献
1
Biliary excretion of antipyrine and its metabolites after cholecystectomy.胆囊切除术后安替比林及其代谢产物的胆汁排泄
Br J Clin Pharmacol. 1988 Feb;25(2):279-80. doi: 10.1111/j.1365-2125.1988.tb03304.x.
2
The absence of significant biliary excretion of antipyrine or its metabolites in humans.在人类中，安替比林或其代谢产物不存在显著的胆汁排泄。
Clin Pharmacol Ther. 1987 Jan;41(1):85-7. doi: 10.1038/clpt.1987.14.
3
Effect of secretin on antipyrine elimination during extracorporeal perfusion of the isolated guinea pig liver.促胰液素对豚鼠离体肝脏体外灌注期间安替比林消除的影响。
Acta Physiol Pol. 1978 May-Jun;29(3):267-72.
4
The time course of distribution of antipyrine in dogs and its modification by drugs.安替比林在犬体内的分布时程及其受药物的影响
Arch Int Pharmacodyn Ther. 1965 May;155(1):7-20.
5
Preliminary results of biliary excretion of ramipril after T-drainage in cholecystectomy patients.
J Cardiovasc Pharmacol. 1991;18 Suppl 2:S116-21.
6
Disposition and oxidative metabolism of antipyrine in the rat.安替比林在大鼠体内的处置及氧化代谢
Acta Pharmacol Toxicol (Copenh). 1978 Jul;43(1):64-8. doi: 10.1111/j.1600-0773.1978.tb02234.x.
7
Biliary excretion of diazepam and its metabolites in man.地西泮及其代谢产物在人体中的胆汁排泄。
Acta Pharmacol Toxicol (Copenh). 1975 Sep;37(3):242-9. doi: 10.1111/j.1600-0773.1975.tb00841.x.
8
Biliary excretion of ceftizoxime in humans.
Chemotherapy. 1984;30(4):221-6. doi: 10.1159/000238272.
9
3-Hydroxymethyl antipyrine excretion in urine after an oral dose of antipyrine. A reconsideration of previously published data and synthesis of a pure reference substance.口服安替比林后尿液中3-羟甲基安替比林的排泄。对先前发表数据的重新审视及一种纯参考物质的合成。
Pharmacology. 1982;24(3):181-4. doi: 10.1159/000137594.
10
Studies on digitalis. III. Biliary excretion and enterohepatic circulation of digitoxin and its cardioactive metabolites.
Clin Pharmacol Ther. 1975 Mar;17(3):313-20. doi: 10.1002/cpt1975173313.
引用本文的文献
1
Quantifying hepatic function in the presence of liver disease with phenazone (antipyrine) and its metabolites.利用非那宗（安替比林）及其代谢物对存在肝脏疾病时的肝功能进行定量分析。
Clin Pharmacokinet. 1991 Jan;20(1):50-65. doi: 10.2165/00003088-199120010-00004.
2
The pharmacokinetics of antipyrine and three of its metabolites in the rabbit: intravenous administration of pure metabolites.
Pharm Res. 1991 Dec;8(12):1470-6. doi: 10.1023/a:1015830013451.
本文引用的文献
1
HPLC determination of antipyrine metabolites.高效液相色谱法测定安替比林代谢物
Pharmacology. 1981;23(4):192-202. doi: 10.1159/000137550.
2
Differential effects of enzyme induction on antipyrine metabolite formation.酶诱导作用对安替比林代谢物形成的不同影响。
Br J Clin Pharmacol. 1982 Mar;13(3):379-86. doi: 10.1111/j.1365-2125.1982.tb01389.x.
3
Antipyrine metabolism in relation to polymorphic oxidations of sparteine and debrisoquine.安替比林代谢与司巴丁和异喹胍多态性氧化的关系。
Br J Clin Pharmacol. 1983 Mar;15(3):317-21. doi: 10.1111/j.1365-2125.1983.tb01505.x.
4
The absence of significant biliary excretion of antipyrine or its metabolites in humans.在人类中，安替比林或其代谢产物不存在显著的胆汁排泄。
Clin Pharmacol Ther. 1987 Jan;41(1):85-7. doi: 10.1038/clpt.1987.14.
5
Studies on the different metabolic pathways of antipyrine in man. I. Oral administration of 250, 500 and 1000 mg to healthy volunteers.人体中安替比林不同代谢途径的研究。I. 对健康志愿者口服250、500和1000毫克安替比林。
Br J Clin Pharmacol. 1979 Dec;8(6):529-37. doi: 10.1111/j.1365-2125.1979.tb01040.x.
6
The antipyrine test in clinical pharmacology: conceptions and misconceptions.临床药理学中的安替比林试验：概念与误解
Clin Pharmacol Ther. 1979 Sep;26(3):275-86. doi: 10.1002/cpt1979263275.
Zotero 插件